The following are today's upgrades for Validea's Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth, reasonable valuations and low debt.
The following are today's upgrades for Validea's Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that have low P/B and P/E ratios, along with low debt and solid long-term earnings growth.
Fresh from saying it was ready to invest as much as $10 billion in India over the next five to seven years, Alphabet's (NASDAQ: GOOG)(NASDAQ: GOOGL) Google is reportedly negotiating a $4 billion investment in telecom and internet provider Jio Platforms, a division of the country
A sports gambling legalization wave is under way. In May 2018, The Supreme Court overturned a federal law passed in 1992 that banned sports gambling in most states. Since then, 22 states (plus Washington, D.C.) have legalized the activity.
One company wants you to see the world. The other company wants you to show you its World. What if you can't have the best of both worlds? What if you could only own one? Booking Holdings (NASDAQ: BKNG) is the top dog when it comes to online travel portals. Disney (NYSE: DIS) is
The coronavirus pandemic revealed a major weakness in the business model of Diageo (NYSE: DEO), namely that its operations are too tied to restaurants, bars, and clubs. Because of the shutdown caused by the pandemic, 20% of Diageo's North American business was put at risk, as w
(RTTNews) - AutoNation Inc. (AN) said Tuesday that its chief executive officer Cheryl Miller has decided not to return from her leave of absence, and has resigned as of July 14, 2020. She has also resigned from the Board of Directors.
Intellia Therapeutics (NASDAQ: NTLA) is a biotech company that focuses on gene editing, a relatively new technology that could allow scientists to devise therapies for otherwise impossible-to-treat conditions. As with any new technology, those who invest in it early enough could
Some might think of big pharmaceutical companies as cutthroat corporations only interested in their own profits and self-preservation. But what if told you that several big pharma companies are together investing close to $1 billion to help smaller biotechs?
Mission Impossible 7. Wonder Woman 1984. Stranger Things 4. The season 10 finale of The Walking Dead. These are just a handful of the motion pictures and television shows that have been delayed because actors and production crews can't film under the threat of the novel coronavi
Banks are hit-or-miss investments right now, due to the state of the economy. But one bank you might want to take a swing at is PNC Financial Services (NYSE: PNC).
A third of company audits by Britain's leading accounting firms failed a quality test, the country's accounting watchdog said on Tuesday, piling further pressure on a sector already being questioned over its competence.
Britain's accounting watchdog said on Tuesday that a third of audits by the country's leading accounting firms failed its quality test, piling further pressure on a sector already being questioned over its competence.
(RTTNews) - Grainger plc (GRI.L), on Tuesday, said it agreed to forward fund and acquire a 98-home PRS development at Guildford Station in Surrey for about £37 million. The developer is Solum Regeneration, a joint venture between Network Rail and Kier.
(RTTNews) - Today's Daily Dose brings you news about Altimmune's progress in ints intranasal COVID-19 vaccine candidate, Independent Data Monitoring Committee recommending stopping of Celsion's phase III OPTIMA study, FDA refusing to accept for review CytoDyn's Biologics License
(RTTNews) - Swatch Group (SWGAF.PK, SWGNF.PK) reported first half net result to shareholders of a loss of 303 million Swiss francs compared to profit of 404 million Swiss francs, previous year. Loss per registered share was 1.17 francs compared to profit of 1.56 francs. Operatin
(RTTNews) - European stocks are seen opening lower on Tuesday after the Trump Administration rejected China's expansive claims in the South China Sea, a move that Beijing criticized as inciting tensions in the region.
(RTTNews) - German drug delivery devices maker Gerresheimer AG (GRRMF.PK) reported Tuesday that its second-quarter net income fell to 29.5 million euros from last year's 47.1 million euros. Earnings per share were 0.92 euro, down from 1.48 euros last year.
Checked
24 minutes 55 seconds ago
This feed is responsible for generating the rss feed related to the topic Markets